These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10529381)

  • 1. Identification of autoantibodies associated with rippling muscles and myasthenia gravis that recognize skeletal muscle proteins: possible relationship of antigens and stretch-activated ion channels.
    Walker GR; Watkins T; Ansevin CF
    Biochem Biophys Res Commun; 1999 Oct; 264(2):430-5. PubMed ID: 10529381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of skeletal muscle autoantigens by expression library screening using sera from autoimmune rippling muscle disease (ARMD) patients.
    Watkins TC; Zelinka LM; Kesic M; Ansevin CF; Walker GR
    J Cell Biochem; 2006 Sep; 99(1):79-87. PubMed ID: 16598745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability.
    Vernino S; Lennon VA
    Muscle Nerve; 2002 Nov; 26(5):702-7. PubMed ID: 12402293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.
    Schoser B; Jacob S; Hilton-Jones D; Müller-Felber W; Kubisch C; Claus D; Goebel HH; Vita G; Vincent A; Toscano A; Van den Bergh P
    Neuromuscul Disord; 2009 Mar; 19(3):223-8. PubMed ID: 19208478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Striational antibodies in myasthenia gravis: reactivity and possible clinical significance.
    Romi F; Skeie GO; Gilhus NE; Aarli JA
    Arch Neurol; 2005 Mar; 62(3):442-6. PubMed ID: 15767509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular mimicry between neurofilaments and titin as the basis for autoimmunity towards skeletal muscle in paraneoplastic myasthenia gravis].
    Wilisch A; Schultz A; Greiner A; Kirchner T; Müller-Hermelink HK; Marx A
    Verh Dtsch Ges Pathol; 1996; 80():261-6. PubMed ID: 9065023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune myasthenia gravis in childhood.
    Andrews PI
    Semin Neurol; 2004 Mar; 24(1):101-10. PubMed ID: 15229797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoimmune targets of heart and skeletal muscles in myasthenia gravis.
    Suzuki S; Utsugisawa K; Yoshikawa H; Motomura M; Matsubara S; Yokoyama K; Nagane Y; Maruta T; Satoh T; Sato H; Kuwana M; Suzuki N
    Arch Neurol; 2009 Nov; 66(11):1334-8. PubMed ID: 19752287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel autoantibodies to a voltage-gated potassium channel Kv1.4 in a severe form of myasthenia gravis.
    Suzuki S; Satoh T; Yasuoka H; Hamaguchi Y; Tanaka K; Kawakami Y; Suzuki N; Kuwana M
    J Neuroimmunol; 2005 Dec; 170(1-2):141-9. PubMed ID: 16182377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nature and Action of Antibodies in Myasthenia Gravis.
    Ruff RL; Lisak RP
    Neurol Clin; 2018 May; 36(2):275-291. PubMed ID: 29655450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acquired rippling muscle disease with myasthenia gravis.
    Greenberg SA
    Muscle Nerve; 2004 Jan; 29(1):143-6. PubMed ID: 14694511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology of myasthenia gravis.
    Hughes BW; Moro De Casillas ML; Kaminski HJ
    Semin Neurol; 2004 Mar; 24(1):21-30. PubMed ID: 15229789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-fiber electromyography during menstrual exacerbation and ovulatory suppression in MuSK antibody-positive myasthenia gravis.
    Stickler DE; Stickler LL
    Muscle Nerve; 2007 Jun; 35(6):808-11. PubMed ID: 17221882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and reactivity patterns of skeletal and heart (SH) reactive autoantibodies in the sera of patients with myasthenia gravis.
    Connor RI; Lefvert AK; Benes SC; Lang RW
    J Neuroimmunol; 1990 Feb; 26(2):147-57. PubMed ID: 2298883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-cardiac ryanodine receptor antibodies in thymoma-associated myasthenia gravis.
    Mygland A; Tysnes OB; Matre R; Aarli JA; Gilhus NE
    Autoimmunity; 1994; 17(4):327-31. PubMed ID: 7948615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mosaic caveolin-3 expression in acquired rippling muscle disease without evidence of myasthenia gravis or acetylcholine receptor autoantibodies.
    Lo HP; Bertini E; Mirabella M; Domazetovska A; Dale RC; Petrini S; D'Amico A; Valente EM; Barresi R; Roberts M; Tozzi G; Tasca G; Cooper ST; Straub V; North KN
    Neuromuscul Disord; 2011 Mar; 21(3):194-203. PubMed ID: 21295981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.
    Aarli JA; Stefansson K; Marton LS; Wollmann RL
    Clin Exp Immunol; 1990 Nov; 82(2):284-8. PubMed ID: 2242609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repertoires of autoantibodies against homologous eye muscle in ocular and generalized myasthenia gravis differ.
    Zimmermann CW; Eblen F
    Clin Investig; 1993 Jun; 71(6):445-51. PubMed ID: 8353403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro.
    Skeie GO; Mygland A; Treves S; Gilhus NE; Aarli JA; Zorzato F
    Muscle Nerve; 2003 Jan; 27(1):81-9. PubMed ID: 12508299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.